// App-Quantinova.ai

1465 : Analysis of tumor-infiltrating lymphocytes (TILs) reveals biologically different subgroups of breast ductal carcinoma in situ

Researchers

Presenter

  • Marie Beguinot-Cornillon

Principal Investigators

  • Marie-Melanie Dauplat

  • Fabrice Kwiatkowski

  • Guillaume Lebouedec

  • Lucie Tixier

  • Christophe Pomel

  • Frederique Penault-Llorca

  • Nina Radosevic-Robin

Medical Centers

  • Surgical Oncology, Pathology, Jean Perrin Cancer Center (JPCC) ERTICa Research Team, University of Auvergne EA , Clermont-Ferrand Master Program in Biology and Health Sciences, University Paris-East Val-de-Marne (UPEC), Creteil, France

  • Pathology, JPCC ERTICa Research Team, University of Auvergne EA , Clermont-Ferrand, France

  • Pathology, JPCC ERTICa Research Team, University of Auvergne EA , Clermont-Ferrand, France

  • Surgical Oncology, JPCC, Clermont-Ferrand, France

  • Pathology, JPCC, Clermont-Ferrand, France

  • Pathology, JPCC ERTICa Research Team, University of Auvergne EA , Clermont-Ferrand, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • B-lymphocyte antigen CD20

  • Cluster of Differentiation 38

  • Cluster of Differentiation 4

  • Progesterone receptor

  • Proliferation marker protein Ki-67

  • Cluster of differentiation 8A

  • erb-b2 receptor tyrosine kinase 2

  • Forkhead Box P3

  • tumor-infiltrating lymphocytes

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved